Cell Development Inhibition By Nanoparticles, A Promising Approach For Cancer Therapy
- سال انتشار: 1397
- محل انتشار: اولین کنگره ملی نانو فناوری در علوم سلامت
- کد COI اختصاصی: NHSMED01_005
- زبان مقاله: انگلیسی
- تعداد مشاهده: 382
نویسندگان
Ph.D. Candidate of NanoBiotechnology, Tehran University, Iran
Associate Professor, Tehran University, Iran
Associate Professor, Tehran University of Medical Sciences, Iran
چکیده
Background and ObjectiveMontmorillonite (Mont), a FDA-approved mineral (1), has been widely used in pharmacy industry as both excipient and active agents (2). In recent years, it was also used as an efficient nanocarrier in many oral drug delivery systems, resulting in increasing the bioavailability as well as reducing the side effects of drugs (3-5). However, there are some limited reports implying (6) or rejecting (7 & 8) the potential of Mont to inhibit cancer cells. Herein, the effect of Mont on the development of cancerous cells was investigated. Materials & MethodsCancerous cell lines including HepG2 (liver), HT-29 (colon), MDA-MB-231 and MCF-7 (breast) were treated by Mont in concentrations ranging from 12 up to 4000 μg/ml and the viability of cell was determined by MTT assay at three repetitions and P values were calculated by T-test.FindingsThe results of MTT assay clearly demonstrated that Mont in concentrations ≥ 200, 300, 300 and 500 μg/ml could significantly (P values ˂ 0.05) reduce the viability in MDA-MB-231, MCF-7, HepG2 and HT-29 cell lines, respectively. These cell lines displayed various stabilities against different concentrations of Mont. For instance, in concentration of 500 μg/ml HT-29 was more resistant than MCF-7, while in concentrations ≥ 1000 μg/ml the viability of MCF-7 was considerably more than HT-29. As well, in three concentrations 500, 750 and 1000 μg/ml, HepG2 did not show any significant difference in viability, whereas HT-29 showed the maximum of differences in viability. However, among all cell lines MDA-MB-231 showed the least viability in all concentrations tested.ConclusionBesides that Mont can be applied in pharmacy industry, as an excipient/active agent as well as a nanocarrier, interestingly it alone can inhibit the development of various cancerous cells. The degree of inhibition is dependent on the type of cells and the concentration of nanoparticles. The potential of Mont can be promising in drug delivery to gastrointestinal cancers and also in hepatic arterial infusion chemotherapy, where Mont will be a carrier for the chemotherapy drugs.کلیدواژه ها
Cancer, Chemotherapy, Nanoparticle, Montmorilloniteمقالات مرتبط جدید
- بررسی رادیوگرافیک خطاهای حین درمان ریشه ی دانشجویان دکترای عمومی سال ۵ و ۶ دانشگاه آزاد اسلامی واحد اصفهان (خوراسگان)
- بررسی رابطه ی بین شاخص توده ی بدنی و پوسیدگی شدید دوران کودکی (S-ECC ) در کودکان شهر اصفهان
- شیوع افسردگی در مبتلایان لیکن پلان دهانی در مراجعین دانشکده ی دندان پزشکی اصفهان
- بررسی همبستگی بین شاخص Decayed, Missing, Filled, Teeth با شاخص های مرتبط با Glomerular Filtration Rate در مراحل مختلف بیماری کلیه در بزرگسالان شهر شاهدیه، یزد
- میزان تطابق مارجین کوپینگ های زیرکونیایی و فلزی سینترون قبل و بعذ از پخت با دو نوع پرسلن مختلف
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.